Cannabis for nerve pain after chemotherapy in breast and colon cancer survivors
Treatments studied
Part of Cancer, Digestive system, Skin clinical trials.
This trial tests whether a cannabis-based product can reduce nerve damage (neuropathy) caused by chemotherapy in people who have finished treatment for breast or colon cancer. It focuses on survivors who still have pain, numbness, or tingling in their hands or feet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You had chemotherapy with a taxane drug (like paclitaxel or docetaxel) or a platinum drug (like cisplatin, oxaliplatin, or carboplatin).
- You still have nerve symptoms like pain, numbness, or tingling that are at least mild (score of 1 or more on a doctor's scale, or over 3 on a 0-10 scale).
- You finished active chemotherapy, radiation, or surgery at least 3 months ago (hormonal therapy is okay).
- You have not used medical cannabis in the past 30 days and can avoid other cannabis products during the study.
- You are willing to use medical cannabis as directed and follow study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a blend of CBG and CBD oils can help relieve nerve pain, tingling, or weakness caused by platinum-based chemotherapy in people with certain gastrointestinal cancers. If you have had colorectal, biliary, pancreatic, esophageal, gastric, or small intestinal cancer and completed chemo in the last 2 years, you may be able to join.
This study tests a diet program delivered online to help reduce nerve damage symptoms like numbness and tingling caused by chemotherapy. It is for cancer survivors who completed treatment and still have these symptoms.
This study looks at the benefits and risks of using cannabis or cannabinoids for cancer patients. It aims to help understand how these products affect symptoms and quality of life during chemotherapy or immunotherapy.
This study looks at “TRP channels,” which are part of how nerves sense pain and temperature, to understand nerve pain (neuropathy) after chemotherapy. It may help improve how future treatments prevent or reduce nerve pain in people who have had certain chemotherapy drugs.
This Phase 2 trial tests duloxetine to see if it safely reduces painful nerve damage caused by chemotherapy (especially taxanes) in people with solid tumors. If you have moderate-to-severe nerve pain and meet lab and heart-safety checks, this study may be an option.
This study tests a new gel (VMD-3866) applied to the skin to treat moderate nerve pain, numbness, or tingling caused by previous chemotherapy. It aims to see if the gel can safely reduce pain for people whose symptoms have been stable for at least 8 weeks.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.